NanoCellect Biomedical, Inc.
NanoCellect is committed to empowering every scientist to make discoveries one cell at a time, with modern and simple technologies for to advance cell based assays that are affordable, compact, and easy-to-use. Our microfluidic flow cytometry platforms enable biomedical scientists to analyze and sort cells required for drug discovery, single cell-omics, cloning, and basic research. The company was founded in late 2009 as a spinout from UCSD and dedicated 6 years developing the foundation of the WOLF’s technology before introducing the WOLF to early adopters in 2016. Initial funding of R&D was graciously provided by multiple NIH SBIR grants and contracts. Additionally, we are backed by Illumina Ventures, FusionX Ventures, Anzu Partners, Agilent Technologies, Vertical Ventures and other private investors.
Company details
Find locations served, office locations and our distributors
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2009
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Initial funding of R&D was graciously provided by multiple NIH SBIR grants and contracts. Additionally, we are backed by Illumina Ventures, FusionX Ventures, Anzu Partners, Agilent Technologies, Vertical Ventures and other private investors.